Up to now, several chemiluminescent immunoassay methods have been established in the clinical detection of tumor markers, such as alpha-fetoprotein (AFP), prostate-specific antigen (PSA), carbohydrate antigen 125 (CA125), and neuron-specific enolase (NSH) [39–42]. Here, KLK3 is linked to neoplasm.